BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16337860)

  • 1. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
    Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
    Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
    Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
    Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1.
    Jhang JS; Narayan G; Murty VV; Mansukhani MM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):114-9. PubMed ID: 15036886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal oncocytomas with rearrangements involving 11q13 contain breakpoints near CCND1.
    Zanssen S; Gunawan B; Fuzesi L; Warburton D; Schon EA
    Cancer Genet Cytogenet; 2004 Mar; 149(2):120-4. PubMed ID: 15036887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.
    Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G
    Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma.
    Brunelli M; Segala D; Delahunt B; Parolini C; Bersani S; Cheng L; Eble JN; Chilosi M; Gobbo S; Martignoni G
    Anticancer Res; 2011 Oct; 31(10):3137-42. PubMed ID: 21965719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
    Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
    Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of renal oncocytosis: a possible model for neoplastic progression.
    Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
    Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
    Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
    Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?
    Al-Saleem T; Balsara BR; Liu Z; Feder M; Testa JR; Wu H; Greenberg RE
    Cancer Genet Cytogenet; 2005 Nov; 163(1):81-5. PubMed ID: 16271962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Delahunt B; Cheng L
    Mod Pathol; 2005 Feb; 18(2):161-9. PubMed ID: 15467713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.
    Rowsell C; Fleshner N; Marrano P; Squire J; Evans A
    J Clin Pathol; 2007 Apr; 60(4):426-8. PubMed ID: 17405978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Garcia E; Li M
    Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.